Author Topic: Serious Adverse Events > risk reduction for COVID-19 hospitalization, in trials  (Read 186 times)

admin

  • Administrator
  • Hero Member
  • *****
  • Posts: 3081
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4125239

"Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials"

"Results: Pfizer and Moderna mRNA COVID-19 vaccines were associated with an increased risk of serious adverse events of special interest, with an absolute risk increase of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95% CI -0.4 to 20.6 and -3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an absolute risk increase of serious adverse events of special interest of 12.5 per 10,000 (95% CI 2.1 to 22.9). The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials (2.3 and 6.4 per 10,000 participants, respectively)."
« Last Edit: July 02, 2022, 08:57:00 AM by admin »
Over a million Americans have died completely unnecessary, horrific, deaths from COVID-19. Do you have a plan in place to help your family dodge the average $73,300 COVID hospital bill, through prevention and a $20 EARLY treatment protocol? https://www.covidtreatmentoptions.com/